Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of switching from reference adalimumab to CT-P17 (100 mg/ml): 52-week randomized, double-blind study in rheumatoid arthritis.
Furst DE, Jaworski J, Wojciechowski R, Wiland P, Dudek A, Krogulec M, Jeka S, Zielinska A, Trefler J, Bartnicka-Maslowska K, Krajewska-Wlodarczyk M, Klimiuk PA, Lee SJ, Kim SH, Bae YJ, Yang GE, Yoo JK, Kay J, Keystone E. Furst DE, et al. Rheumatology (Oxford). 2022 Apr 11;61(4):1385-1395. doi: 10.1093/rheumatology/keab460. Rheumatology (Oxford). 2022. PMID: 34142111 Free PMC article. Clinical Trial.
Efficacy and safety of biosimilar CT-P17 versus reference adalimumab in subjects with rheumatoid arthritis: 24-week results from a randomized study.
Kay J, Jaworski J, Wojciechowski R, Wiland P, Dudek A, Krogulec M, Jeka S, Zielinska A, Trefler J, Bartnicka-Maslowska K, Krajewska-Wlodarczyk M, Klimiuk PA, Lee SJ, Bae YJ, Yang GE, Yoo JK, Furst DE, Keystone E. Kay J, et al. Arthritis Res Ther. 2021 Feb 5;23(1):51. doi: 10.1186/s13075-020-02394-7. Arthritis Res Ther. 2021. PMID: 33546755 Free PMC article. Clinical Trial.
Aseptic Abscess Syndrome in Rheumatoid Arthritis Patient.
Owczarczyk-Saczonek A, Kasprowicz-Furmańczyk M, Kuna J, Klimek P, Krajewska-Włodarczyk M. Owczarczyk-Saczonek A, et al. Among authors: krajewska wlodarczyk m. Medicina (Kaunas). 2022 Sep 27;58(10):1354. doi: 10.3390/medicina58101354. Medicina (Kaunas). 2022. PMID: 36295515 Free PMC article.
Trial of Anti-BDCA2 Antibody Litifilimab for Cutaneous Lupus Erythematosus.
Werth VP, Furie RA, Romero-Diaz J, Navarra S, Kalunian K, van Vollenhoven RF, Nyberg F, Kaffenberger BH, Sheikh SZ, Radunovic G, Huang X, Clark G, Carroll H, Naik H, Gaudreault F, Meyers A, Barbey C, Musselli C, Franchimont N; LILAC Trial Investigators. Werth VP, et al. N Engl J Med. 2022 Jul 28;387(4):321-331. doi: 10.1056/NEJMoa2118024. N Engl J Med. 2022. PMID: 35939578 Clinical Trial.
[Sarcopenia in rheumatoid arthritis].
Krajewska-Włodarczyk M. Krajewska-Włodarczyk M. Wiad Lek. 2016;69(3 pt 2):542-547. Wiad Lek. 2016. PMID: 27717942 Review. Polish.
[Sarcopenia in rheumatoid arthritis].
Krajewska-Włodarczyk M. Krajewska-Włodarczyk M. Wiad Lek. 2016;69(3 pt 2):542-547. Wiad Lek. 2016. PMID: 28478423 Polish.
Trial of Anti-BDCA2 Antibody Litifilimab for Systemic Lupus Erythematosus.
Furie RA, van Vollenhoven RF, Kalunian K, Navarra S, Romero-Diaz J, Werth VP, Huang X, Clark G, Carroll H, Meyers A, Musselli C, Barbey C, Franchimont N; LILAC Trial Investigators. Furie RA, et al. N Engl J Med. 2022 Sep 8;387(10):894-904. doi: 10.1056/NEJMoa2118025. N Engl J Med. 2022. PMID: 36069871 Clinical Trial.
The effect of therapy on TRM in psoriatic lesions.
Owczarczyk-Saczonek A, Kasprowicz-Furmańczyk M, Czerwińska J, Krajewska-Włodarczyk M, Placek W. Owczarczyk-Saczonek A, et al. Postepy Dermatol Alergol. 2022 Feb;39(1):209-220. doi: 10.5114/ada.2021.113125. Epub 2022 Feb 4. Postepy Dermatol Alergol. 2022. PMID: 35369631 Free PMC article.
42 results